Australia markets closed

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW)

Taiwan - Taiwan Delayed price. Currency in TWD
Add to watchlist
46.00-0.30 (-0.65%)
At close: 01:30PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 3.59B
Enterprise value 4.53B
Trailing P/E 13.66
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.73
Price/book (mrq)1.07
Enterprise value/revenue 2.17
Enterprise value/EBITDA 8.30

Trading information

Stock price history

Beta (5Y monthly) 0.73
52-week change 3-53.04%
S&P500 52-week change 321.33%
52-week high 3102.50
52-week low 343.60
50-day moving average 348.32
200-day moving average 356.26

Share statistics

Avg vol (3-month) 3302.71k
Avg vol (10-day) 3201.01k
Shares outstanding 577.56M
Implied shares outstanding 677.99M
Float 855.99M
% held by insiders 140.91%
% held by institutions 11.86%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.3
Forward annual dividend yield 42.81%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 31.73%
5-year average dividend yield 42.21
Payout ratio 438.35%
Dividend date 3N/A
Ex-dividend date 424 July 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 12.70%
Operating margin (ttm)11.70%

Management effectiveness

Return on assets (ttm)3.60%
Return on equity (ttm)8.10%

Income statement

Revenue (ttm)2.09B
Revenue per share (ttm)26.90
Quarterly revenue growth (yoy)-16.00%
Gross profit (ttm)N/A
EBITDA 473.81M
Net income avi to common (ttm)264.91M
Diluted EPS (ttm)3.39
Quarterly earnings growth (yoy)-36.50%

Balance sheet

Total cash (mrq)269.57M
Total cash per share (mrq)3.48
Total debt (mrq)1.21B
Total debt/equity (mrq)36.05%
Current ratio (mrq)2.15
Book value per share (mrq)43.19

Cash flow statement

Operating cash flow (ttm)-66.27M
Levered free cash flow (ttm)-647.7M